Sales of antiviral drugs setting new records in Russia

Sales of antiviral drugs in Russia are rapidly growing amid the ongoing pandemic in the country and the current high demand for them from local population, according to a recent report from DSM Group, the Russian pharma analytics company.

The current sales of antiviral drugs in the Russian market are almost close to last year's highs of mid-October - early November.

Among the best-selling drugs currently are arbidol and ingavirin with a share of sales of 33.1% and 14.8%, respectively. They are followed by areplivir, kagocel, ergoferon, amixin and triazavirine.